Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Involvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteries.

Engholm M, Pinilla E, Mogensen S, Matchkov V, Hedegaard ER, Chen H, Mulvany MJ, Simonsen U.

Br J Pharmacol. 2016 Mar;173(5):839-55. doi: 10.1111/bph.13393. Epub 2016 Jan 27.

2.

Brief serotonin exposure initiates arteriolar inward remodeling processes in vivo that involve transglutaminase activation and actin cytoskeleton reorganization.

Foote CA, Castorena-Gonzalez JA, Staiculescu MC, Clifford PS, Hill MA, Meininger GA, Martinez-Lemus LA.

Am J Physiol Heart Circ Physiol. 2016 Jan 15;310(2):H188-98. doi: 10.1152/ajpheart.00666.2015. Epub 2015 Nov 13.

3.

Regulation of allergic lung inflammation by endothelial cell transglutaminase 2.

Soveg F, Abdala-Valencia H, Campbell J, Morales-Nebreda L, Mutlu GM, Cook-Mills JM.

Am J Physiol Lung Cell Mol Physiol. 2015 Sep 15;309(6):L573-83. doi: 10.1152/ajplung.00199.2015. Epub 2015 Jul 24.

4.

Immunomodulatory effects mediated by serotonin.

Arreola R, Becerril-Villanueva E, Cruz-Fuentes C, Velasco-Velázquez MA, Garcés-Alvarez ME, Hurtado-Alvarado G, Quintero-Fabian S, Pavón L.

J Immunol Res. 2015;2015:354957. doi: 10.1155/2015/354957. Epub 2015 Apr 19. Review.

5.

Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.

Nurminskaya M, Beazley KE, Smith EP, Belkin AM.

J Vasc Res. 2014;51(6):418-28. doi: 10.1159/000369461. Epub 2015 Jan 22.

6.

Transglutaminase activity is decreased in large arteries from hypertensive rats compared with normotensive controls.

Petersen-Jones HG, Johnson KB, Hitomi K, Tykocki NR, Thompson JM, Watts SW.

Am J Physiol Heart Circ Physiol. 2015 Mar 15;308(6):H592-602. doi: 10.1152/ajpheart.00402.2014. Epub 2015 Jan 16.

7.

Tissue transglutaminase promotes serotonin-induced AKT signaling and mitogenesis in pulmonary vascular smooth muscle cells.

Penumatsa K, Abualkhair S, Wei L, Warburton R, Preston I, Hill NS, Watts SW, Fanburg BL, Toksoz D.

Cell Signal. 2014 Dec;26(12):2818-25. doi: 10.1016/j.cellsig.2014.09.002. Epub 2014 Sep 15.

8.

Biotechnological applications of transglutaminases.

Rachel NM, Pelletier JN.

Biomolecules. 2013 Oct 22;3(4):870-88. doi: 10.3390/biom3040870.

9.

Transglutaminase regulation of cell function.

Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GV, Mehta K.

Physiol Rev. 2014 Apr;94(2):383-417. doi: 10.1152/physrev.00019.2013. Review.

10.

Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

Penumatsa KC, Fanburg BL.

Am J Physiol Lung Cell Mol Physiol. 2014 Feb 15;306(4):L309-15. doi: 10.1152/ajplung.00321.2013. Epub 2013 Dec 27. Review.

11.

The obligatory role of the actin cytoskeleton on inward remodeling induced by dithiothreitol activation of endogenous transglutaminase in isolated arterioles.

Castorena-Gonzalez JA, Staiculescu MC, Foote CA, Polo-Parada L, Martinez-Lemus LA.

Am J Physiol Heart Circ Physiol. 2014 Feb 15;306(4):H485-95. doi: 10.1152/ajpheart.00557.2013. Epub 2013 Dec 13.

12.

Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.

Liu C, Wang W, Parchim N, Irani RA, Blackwell SC, Sibai B, Jin J, Kellems RE, Xia Y.

Hypertension. 2014 Feb;63(2):353-61. doi: 10.1161/HYPERTENSIONAHA.113.02361. Epub 2013 Nov 4.

13.

Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks.

Amireault P, Sibon D, Côté F.

ACS Chem Neurosci. 2013 Jan 16;4(1):64-71. doi: 10.1021/cn300154j. Epub 2012 Nov 7. Review.

14.

Histaminylation of glutamine residues is a novel posttranslational modification implicated in G-protein signaling.

Vowinckel J, Stahlberg S, Paulmann N, Bluemlein K, Grohmann M, Ralser M, Walther DJ.

FEBS Lett. 2012 Nov 2;586(21):3819-24. doi: 10.1016/j.febslet.2012.09.027. Epub 2012 Sep 26.

15.

Serotonin potentiates transforming growth factor-beta3 induced biomechanical remodeling in avian embryonic atrioventricular valves.

Buskohl PR, Sun MJ, Thompson RP, Butcher JT.

PLoS One. 2012;7(8):e42527. doi: 10.1371/journal.pone.0042527. Epub 2012 Aug 6. Erratum in: PLoS One. 2012;7(10). doi:10.1371/annotation/7fdd5c53-e8ab-40b5-b297-e82c06a06e70. Sun, Michelle L [corrected to Sun, Michelle J].

16.

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

Sauls K, de Vlaming A, Harris BS, Williams K, Wessels A, Levine RA, Slaugenhaupt SA, Goodwin RL, Pavone LM, Merot J, Schott JJ, Le Tourneau T, Dix T, Jesinkey S, Feng Y, Walsh C, Zhou B, Baldwin S, Markwald RR, Norris RA.

Cardiovasc Res. 2012 Oct 1;96(1):109-19. doi: 10.1093/cvr/cvs238. Epub 2012 Jul 25.

17.

Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan.

Abdala-Valencia H, Berdnikovs S, McCary CA, Urick D, Mahadevia R, Marchese ME, Swartz K, Wright L, Mutlu GM, Cook-Mills JM.

Am J Physiol Lung Cell Mol Physiol. 2012 Oct 15;303(8):L642-60. doi: 10.1152/ajplung.00406.2011. Epub 2012 Jul 27.

18.

Serotonylated fibronectin is elevated in pulmonary hypertension.

Wei L, Warburton RR, Preston IR, Roberts KE, Comhair SA, Erzurum SC, Hill NS, Fanburg BL.

Am J Physiol Lung Cell Mol Physiol. 2012 Jun 15;302(12):L1273-9. doi: 10.1152/ajplung.00082.2012. Epub 2012 Apr 20.

19.

Cellular functions of tissue transglutaminase.

Nurminskaya MV, Belkin AM.

Int Rev Cell Mol Biol. 2012;294:1-97. doi: 10.1016/B978-0-12-394305-7.00001-X. Review.

20.

Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2.

Johnson KB, Petersen-Jones H, Thompson JM, Hitomi K, Itoh M, Bakker EN, Johnson GV, Colak G, Watts SW.

Am J Physiol Heart Circ Physiol. 2012 Apr 1;302(7):H1355-66. doi: 10.1152/ajpheart.00918.2011. Epub 2012 Feb 3.

Supplemental Content

Support Center